Replies to post #1401 on EPS & Earnings ... Hits & Misses

[madrose1]

AMGN $53.56 target and Aranesp estimates lowered on CMS changes-MP@FBRC
Friedman Billings lowered their US Aranesp sales estimates for 2007-2012 and their target to $52 from $55. They now see 2007 Aranesp sales of $2.14B, down from $2.34B and EPS of $4.22, down from $4.28. :theflyonthewall